---
figid: PMC9588328__ECAM2022-1911311.003
pmcid: PMC9588328
image_filename: ECAM2022-1911311.003.jpg
figure_link: /pmc/articles/PMC9588328/figure/fig3/
number: Figure 3
figure_title: ''
caption: 'PFGS combined with Sor inhibited the expression of NF-κB, HIF-2α, and SerpinB3
  in H22 tumor-bearing mice in vivo. (a) Immunostaining indicated that PFGS combined
  with Sor downregulated the expression of NF-κB, HIF-2α, and SerpinB3 in tumor tissue
  (n = 3). (b–d) Statistics chart. Data are presented as the mean ± SD. ∗p < 0.05
  compared with the control group; ∗∗p < 0.01 compared with the control group; #p
  < 0.05 compared with the Sor group.'
article_title: Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide
  Mixture on Liver Cancer via the NF-κB-HIF-2α-SerpinB3 Pathway.
citation: Jun-Fei Li, et al. Evid Based Complement Alternat Med. 2022;2022:1911311.
year: '2022'

doi: 10.1155/2022/1911311
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
